期刊文献+

乳腺癌组织中uPA的表达及其临床意义 被引量:3

Expression and clinical significance of uPA in tissue of breast carcinoma
在线阅读 下载PDF
导出
摘要 目的:研究乳腺癌组织中尿激酶型纤溶酶原激活物(urokinase-type plas-minogen activator,uPA)的表达与肿瘤浸润转移的关系,揭示乳腺癌的浸润转移机制。方法:应用SP免疫组化方法检测102例乳腺癌组织和30例乳腺非癌组织中uPA的表达情况及其与临床病理参数的关系。结果:在102例乳腺癌组织中,uPA的阳性表达率为70.6%(72/102),与良性对照组比较差异有统计学意义,χ2=16.073 5,P=0.005;乳腺癌组织中uPA的阳性表达与腋窝淋巴结转移和临床TNM分期有关;uPA的阳性表达与年龄、肿瘤大小、病理分级无关。结论:乳腺癌uPA的阳性表达与肿瘤的浸润转移密切相关,uPA通过对基底膜和细胞外基质的降解,而促使癌细胞的浸润和转移。因此,检测uPA有助于判断乳腺癌的生物学行为,并提示可能是评估乳腺癌预后的一项有价值的指标。 OBJECTIVE: To investigate the expression of urokinasetype plasminogen activator (uPA) in breast carcinoma tissue, to find out the relationship between tumor invasion and metastasis, and to disclose the mechanism of the tumor invasion and metastasis of breast carcinoma. METHODS: Tissues were obtained from 102 patients with breast carcinoma and 30 ones without breast carcinoma. The expression of uPA was examined by the immunohistochemical technique (streptavidin-peroxidase conjugate method, SP) ,and the results were analysed and correlated with clinicopathological tumor parameters. RESULTS: The positive incidence of uPA expression in 102 cases of breast carcinoma was 70. 6% (72/102), which differentiated significantly that of the control group (X^2 = 16. 0735,P=0. 005). The expression of uPA were related to axillary lymph node metastasis and TNM stage, and the expressions of uPA were not related to age, tumor size and the histologic grade. CONCLUSIONS: uPA expression is closely related to the tumor invasion and metastasis of breast carcinoma, uPA is involved in the processes leading to the degradation reaction of basement membrane and extracellular matrix, which can damage basement membrane and extracellular matrix leading to the tumor invasion and metastasis. Detection of this index may be helpful for judging biologic behavior of breast carcinoma,which suggests that it is a useful prognostic indicator for breast carcinoma.
出处 《肿瘤防治杂志》 CAS 2005年第16期1244-1247,共4页 China Journal of Cancer Prevention and Treatment
基金 福州市科委基金(2001350102000709)
关键词 乳腺肿瘤/病理学 免疫组织化学 尿激酶 纤溶酶原激活剂/分析 预后 breast neoplasms/pathology immunohistochemistry uurokinase plasminogen activator/analysis prognosis
  • 相关文献

参考文献9

  • 1Bloom H,Richardson W. Histological drading and prognosis in breast cancer [J]. Br J Cancer,1957,9:359-377.
  • 2Shimizu M, Saitoh Y,Itoh H. Immunohistochemical staining of Haras oncogene product in normal, benign,and malignant human pancreatic tissues [J]. Hum Pathol,1990, 21(6) :607-612.
  • 3Dano K,Andreasen P A, Grondahl-Hansen K, et al. Plasminogen activators, tissuse degradation and cancer[J]. Adv Cancer Res, 1985,44(2) :139-266.
  • 4Duggan C, Maguire T, Mcdermott E, et al. Urokinase plasminogen activator and urokinase plasminogen activator receptor in breast cancer[J]. Int J Cancer, 1995,61(3) :597-600.
  • 5Del Vecchio S, Stoppelli M P, Carriero M V, et al. Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography:comparison with urokinase levels[J]. Cancer Res, 1993,53(13) :3198-3206.
  • 6Carriero M V, Franco P, Del Vecchio S, et al. Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies[J]. Cancer Res,1994,54 (20):5445- 5454.
  • 7Hasui Y, Marutsuka K, Nishi S, et al. The content of urokinase-type plasminogen activator and tumor recurrence in superficial bladder cancer[J]. J Urol, 1994,151 (1):16-20.
  • 8Rothenberg M L, Nelson A R, Hande K R. New drugs on the horizon: Matrix metalloproteinase inhibitors [J]. Stem Cells,1999, 17(4):237-240.
  • 9Hsu D W, Efird J T, Hedley whyte E T, et al. Prognostic role of urokinase-type plasminogen activator in human gliomas[J].AM J Pathol,1995,147(1) :114-123.

同被引文献24

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部